LK-PRAT002

N/A

Report date: 2025/08/22 17:56:54

Base Information

Drug NameLK-PRAT002
Drug Alias NameLK-PRAT002
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLiveKidney.Bio
China Registration ClassN/A

Develop Information

Active CompaniesLiveKidney.Bio
Inactive CompaniesN/A
Active IndicationsMetabolic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A